Endoscopic surveillance of XXXX lesions: current knowledge and future directions.

@entity1 @entity1944 @entity1127 @entity355 @entity75 @entity344 @entity14 @entity420 @entity356
PURPOSE OF REVIEW: Provide an evidence-based resource for the surveillance of @entity344 lesions, focusing on the scientific articles reported recently. RECENT FINDINGS: No randomized controlled clinical trials exist to definitively support the efficacy of surveillance programs for @entity355 and @entity356 . However, surveillance of these @entity75 is recommended by some of the leading organizations. To optimize the usefulness of surveillance programs, targeting high-risk @entity1 might maximize its benefits. A @entity355 segment of at least 3cm and evidence of @entity1944 can help stratify those @entity1 at highest risk for progression to @entity420 . The location, extent, and severity of @entity1944 are indicators of risk of developing @entity356 . @entity1 with extensive @entity1944 should be offered endoscopic surveillance. Quality in the baseline colonoscopy is crucial to decrease the risk of interval @entity14 . The importance of serrated @entity1127 , as well as their surveillance intervals, is emphasized. SUMMARY: To optimize the usefulness of surveillance programs, targeting high-risk @entity1 might maximize its benefits. Future research is needed to design more effective surveillance strategies. Recently, emerging imaging techniques hold promise for improving sensitivity of endoscopic surveillance of premalignant conditions in the gastrointestinal tract.
